first glp-1 approved for weight loss BREAKING: The FDA has the oral pill obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill The FDA has approved the

Um, research shows it's two to three months in that people lose, start to lose more of their weight for us

Rare serious risks include pancreatitis and gallbladder issues

Pfizer was hoping to throw its hat into the ring, but now it seems the pharma company has taken itself out of the running at least for now

Since the use of GLP-1-based weight-loss treatment is in high demand, telehealth services like MEDVi will probably be discussed in the context of access, affordability, and clinical supervision in obesity care

Its important that patients have all the information they need to talk to their provider and together, assess the risk/benefits of this medication

[DOI] [PubMed] [Google Scholar] 8.Dombrowski S.U., Knittle K., Avenell A., Arajo-Soares V., Sniehotta F.F